Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Dimarchi

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Frontiers in Endocrinology|March 18, 2022
Peptide Model of the Mutant Proinsulin Syndrome. II. Nascent Structure and Biological ImplicationsYanwu Yang, Michael D Glidden, Balamurugan Dhayalan, et al.
Biochemistry|March 20, 2026
A High-Potency Protein That Normalizes Body Weight in DIO Mice through Triple Agonism at FGF21, GLP1, and GIP ReceptorsFlorence M Brunel, Sebastian D Parlee, Pengyun Li, et al.
Diabetologia|December 21, 2014
GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) miceRobert W Schwenk, Christian Baumeier, Brian Finan, et al.
Molecular Metabolism|May 3, 2017
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female miceSigrid Jall, Stephan Sachs, Christoffer Clemmensen, et al.
Analytical Chemistry|July 31, 2010
Combinatorial libraries of synthetic peptides as a model for shotgun proteomicsBrian C Bohrer, Yong Fuga Li, James P Reilly, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 18, 2013
Glucagon-like peptide-1 receptor-mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic β-cellsRamya S Kuna, Shravan Babu Girada, Suman Asalla, et al.
Experimental Neurology|November 16, 2016
Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injuryIan A Tamargo, Miaad Bader, Yazhou Li, et al.
Experimental Neurology|November 16, 2019
Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injuryYazhou Li, Elliot J Glotfelty, Inbar Namdar, et al.
ACS Chemical Biology|October 14, 2010
A novel human-based receptor antagonist of sustained action reveals body weight control by endogenous GLP-1James T Patterson, Nickki Ottaway, Vasily M Gelfanov, et al.
Bone|May 13, 2026
Semaglutide, at a dose that produces modest weight loss, induces mild suppression of bone remodeling in healthy control rats and those with chronic kidney diseaseMatthew R Allen, Corinne E Metzger, Neal X Chen, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Frontiers in Endocrinology|March 18, 2022
Peptide Model of the Mutant Proinsulin Syndrome. II. Nascent Structure and Biological ImplicationsYanwu Yang, Michael D Glidden, Balamurugan Dhayalan, et al.
Biochemistry|March 20, 2026
A High-Potency Protein That Normalizes Body Weight in DIO Mice through Triple Agonism at FGF21, GLP1, and GIP ReceptorsFlorence M Brunel, Sebastian D Parlee, Pengyun Li, et al.
Diabetologia|December 21, 2014
GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) miceRobert W Schwenk, Christian Baumeier, Brian Finan, et al.
Molecular Metabolism|May 3, 2017
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female miceSigrid Jall, Stephan Sachs, Christoffer Clemmensen, et al.
Analytical Chemistry|July 31, 2010
Combinatorial libraries of synthetic peptides as a model for shotgun proteomicsBrian C Bohrer, Yong Fuga Li, James P Reilly, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 18, 2013
Glucagon-like peptide-1 receptor-mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic β-cellsRamya S Kuna, Shravan Babu Girada, Suman Asalla, et al.
Experimental Neurology|November 16, 2016
Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injuryIan A Tamargo, Miaad Bader, Yazhou Li, et al.
Experimental Neurology|November 16, 2019
Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injuryYazhou Li, Elliot J Glotfelty, Inbar Namdar, et al.
ACS Chemical Biology|October 14, 2010
A novel human-based receptor antagonist of sustained action reveals body weight control by endogenous GLP-1James T Patterson, Nickki Ottaway, Vasily M Gelfanov, et al.
Bone|May 13, 2026
Semaglutide, at a dose that produces modest weight loss, induces mild suppression of bone remodeling in healthy control rats and those with chronic kidney diseaseMatthew R Allen, Corinne E Metzger, Neal X Chen, et al.
Pageof 13